Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma ; volume:30 ; number:3 ; day:16 ; month:2 ; year:2024 ; pages:785-796 ; date:3.2024
Nature medicine ; 30, Heft 3 (16.2.2024), 785-796, 3.2024
- Urheber
-
Björk, Johannes R.
Bolte, Laura A.
Thomas, Andrew Maltez
Lee, Karla A.
Rossi, Niccolo
Wind, Thijs T.
Smit, Lotte M.
Armanini, Federica
Asnicar, Francesco
Blanco-Miguez, Aitor
Board, Ruth
Calbet-Llopart, Neus
Derosa, Lisa
Dhomen, Nathalie
Brooks, Kelly
Harland, Mark
Harries, Mark
Lorigan, Paul
Manghi, Paolo
Marais, Richard
Newton-Bishop, Julia
Nezi, Luigi
Pinto, Federica
Potrony, Miriam
Puig, Susana
Serra-Bellver, Patricio
Shaw, Heather M.
Tamburini, Sabrina
Valpione, Sara
Waldron, Levi
Zitvogel, Laurence
Zolfo, Moreno
Vries, Elisabeth G. E. de
Nathan, Paul
Fehrmann, Rudolf S. N.
Spector, Tim D.
Bataille, Véronique
Segata, Nicola
Hospers, Geke A. P.
Weersma, Rinse K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-024-02803-3
- URN
-
urn:nbn:de:101:1-2405230727419.353168221035
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Björk, Johannes R.
- Bolte, Laura A.
- Thomas, Andrew Maltez
- Lee, Karla A.
- Rossi, Niccolo
- Wind, Thijs T.
- Smit, Lotte M.
- Armanini, Federica
- Asnicar, Francesco
- Blanco-Miguez, Aitor
- Board, Ruth
- Calbet-Llopart, Neus
- Derosa, Lisa
- Dhomen, Nathalie
- Brooks, Kelly
- Harland, Mark
- Harries, Mark
- Lorigan, Paul
- Manghi, Paolo
- Marais, Richard
- Newton-Bishop, Julia
- Nezi, Luigi
- Pinto, Federica
- Potrony, Miriam
- Puig, Susana
- Serra-Bellver, Patricio
- Shaw, Heather M.
- Tamburini, Sabrina
- Valpione, Sara
- Waldron, Levi
- Zitvogel, Laurence
- Zolfo, Moreno
- Vries, Elisabeth G. E. de
- Nathan, Paul
- Fehrmann, Rudolf S. N.
- Spector, Tim D.
- Bataille, Véronique
- Segata, Nicola
- Hospers, Geke A. P.
- Weersma, Rinse K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade